Lista de obras - Mark Harrison - Dominio Público Uruguay

A Cost-Benefit Analysis of Teaching and Learning Technology in a Faculty of Pharmaceutical Sciences

artículo científico publicado en 2019

A secondary analysis of the moderating effects of depression and multimorbidity on the effectiveness of a chronic disease self-management programme

artículo científico publicado en 2011

Assessment of Condition and Medication Knowledge Gaps Among Atrial Fibrillation Patients: A Systematic Review and Meta-analysis

artículo científico publicado en 2019

Assessment of atrial fibrillation patients' education needs from patient and clinician perspectives: A qualitative descriptive study

scientific article published on 16 November 2018

Association Between Symptom Duration and Patient-Reported Outcomes Before and After Hip Replacement Surgery

artículo científico publicado en 2020

Association of functional outcome with both personal- and area-level socioeconomic inequalities in patients with inflammatory polyarthritis

artículo científico publicado en 2009

Attitude to health risk in the Canadian population: a cross-sectional survey.

artículo científico publicado en 2016

Communicating Uncertainty in Benefits and Harms: A Review of Patient Decision Support Interventions.

artículo científico publicado en 2016

Communicating uncertainty in cancer prognosis: A review of web-based prognostic tools

artículo científico publicado en 2018

Construct and criterion validity of the short form-6D utility measure in patients with systemic lupus erythematosus.

artículo científico publicado en 2012

Cost-Effectiveness of a School-Based Social and Emotional Learning Intervention: Evidence from a Cluster-Randomised Controlled Trial of the Promoting Alternative Thinking Strategies Curriculum

scientific article published on 01 April 2020

Delivery of paediatric rheumatology care in the UK--the projected shortfall

artículo científico publicado en 2010

Developments in rheumatology consultant manpower provision: the BSR/arc Workforce Register 2003–05

artículo científico publicado en 2006

Do patients and health care providers have discordant preferences about which aspects of treatments matter most? Evidence from a systematic review of discrete choice experiments

artículo científico

Does Introducing Imprecision around Probabilities for Benefit and Harm Influence the Way People Value Treatments?

artículo científico publicado en 2015

Early cost-effectiveness modeling for better decisions in public research investment of personalized medicine technologies

scientific article published on 10 December 2018

Economics of stratified medicine in rheumatoid arthritis

artículo científico publicado en 2014

Effect of a national primary care pay for performance scheme on emergency hospital admissions for ambulatory care sensitive conditions: controlled longitudinal study

artículo científico publicado en 2014

Exploring the mechanisms of change in the chronic disease self-management programme: secondary analysis of data from a randomised controlled trial

artículo científico publicado en 2010

Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis

artículo científico publicado en 2010

Health state utility values: a description of their development and application for rheumatic diseases

artículo científico publicado en 2008

Health-related quality of life, smoking and carotid atherosclerosis in white British women with systemic lupus erythematosus.

artículo científico publicado en 2009

How important is mode of administration in treatments for rheumatic diseases and related conditions?

artículo científico

Impact of brand drug discount cards on private insurer, government and patient expenditures

scientific article published on 01 November 2019

Incentives in Rheumatology: the Potential Contribution of Physician Responses to Financial Incentives, Public Reporting, and Treatment Guidelines to Health Care Sustainability.

artículo científico publicado en 2016

Including adverse drug events in economic evaluations of anti-tumour necrosis factor-α drugs for adult rheumatoid arthritis: a systematic review of economic decision analytic models.

artículo científico

Mapping the disease-specific LupusQoL to the SF-6D.

artículo científico publicado en 2014

Modelling the cost effectiveness of TNF- antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry

article

Multivariate meta-analysis of mixed outcomes: a Bayesian approach

artículo científico publicado en 2013

OMERACT 10 Patient Perspective Virtual Campus: valuing health; measuring outcomes in rheumatoid arthritis fatigue, RA sleep, arthroplasty, and systemic sclerosis; and clinical significance of changes in health

artículo científico publicado en 2011

Operationalizing Neuroimaging for Disorders of Consciousness in the Canadian Context

artículo científico publicado en 2018

Parity, time since last live birth and long-term functional outcome: a study of women participating in the Norfolk Arthritis Register ⬇️

artículo científico publicado en 2011

Patient Satisfaction and Costs of Multidisciplinary Models of Care in Rheumatology: a Review of the Recent Literature.

artículo científico publicado en 2018

Patient-provider communication about medication cost in rheumatoid arthritis

scientific article published on 06 June 2020

Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensified treatment with traditional disease modifying anti-rheumatic drugs--results of the British Rheumatoid Outcome Study Group randomized controlled clinic

artículo científico publicado en 2005

Perspectives of patients, first-degree relatives and rheumatologists on preventive treatments for rheumatoid arthritis: a qualitative analysis

scientific article published on 05 July 2018

Potential cost-effectiveness for using patient decision aids to guide osteoporosis treatment.

artículo científico publicado en 2016

Preferences for ‘New’ Treatments Diminish in the Face of Ambiguity

artículo científico publicado en 2016

Preferences of Patients and At-risk Individuals for Preventive Approaches to Rheumatoid Arthritis

artículo científico publicado en 2019

Prevalence of autistic spectrum disorders in Lothian, Scotland: an estimate using the "capture-recapture" technique.

artículo científico publicado en 2006

Preventing rheumatoid arthritis: Preferences for and predicted uptake of preventive treatments among high risk individuals

artículo científico publicado en 2019

Providing an extended use of an otological-specific outcome instrument to derive cost-effectiveness estimates of treatment.

artículo científico publicado en 2015

Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register.

artículo científico publicado en 2008

Reply

artículo científico publicado en 2017

Respondent Understanding in Discrete Choice Experiments: A Scoping Review

artículo científico publicado en 2020

Risk as an attribute in discrete choice experiments: a systematic review of the literature.

artículo científico publicado en 2014

Same question, different answers: a comparison of global health assessments using visual analogue scales

artículo científico publicado en 2009

Societal preferences for rheumatoid arthritis treatments: evidence from a discrete choice experiment

artículo científico publicado en 2015

The Impact of Waiting Time on Health Gains from Surgery: Evidence from a National Patient-reported Outcome Dataset ⬇️

artículo científico publicado en 2015

The OMERACT Initiative. Towards a reference approach to derive QALY for economic evaluations in rheumatology

artículo científico publicado en 2009

The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis

artículo científico publicado en 2009

The impact of medication reviews by community pharmacists

artículo científico publicado en 2016

The relationship between social deprivation, disease outcome measures, and response to treatment in patients with stable, long-standing rheumatoid arthritis.

artículo científico publicado en 2005

The use of routinely collected patient-reported outcome measures in rheumatoid arthritis

artículo científico publicado en 2018

UK rheumatology consultant workforce provision 2007-9: results from the BSR/Arthritis Research UK Consultant Workforce Register

artículo científico publicado en 2011

Use of Bayesian multivariate meta-analysis to estimate the HAQ for mapping onto the EQ-5D questionnaire in rheumatoid arthritis.

scientific article published on January 2014

Using Survival Analysis to Improve Estimates of Life Year Gains in Policy Evaluations.

artículo científico publicado en 2016

Valuing Health for Clinical and Economic Decisions: Directions Relevant for Rheumatologists

article

Variation in healthcare services for specialist genetic testing and implications for planning genetic services: the example of inherited retinal dystrophy in the English NHS.

artículo científico publicado en 2015

Why do patients with inflammatory arthritis often score states "worse than death" on the EQ-5D? An Investigation of the EQ-5D classification system.

artículo científico publicado en 2009

Lista de obras de Mark Harrison

A Cost-Benefit Analysis of Teaching and Learning Technology in a Faculty of Pharmaceutical Sciences

A secondary analysis of the moderating effects of depression and multimorbidity on the effectiveness of a chronic disease self-management programme

Assessment of Condition and Medication Knowledge Gaps Among Atrial Fibrillation Patients: A Systematic Review and Meta-analysis

Assessment of atrial fibrillation patients' education needs from patient and clinician perspectives: A qualitative descriptive study

Association Between Symptom Duration and Patient-Reported Outcomes Before and After Hip Replacement Surgery

Association of functional outcome with both personal- and area-level socioeconomic inequalities in patients with inflammatory polyarthritis

Attitude to health risk in the Canadian population: a cross-sectional survey.

Communicating Uncertainty in Benefits and Harms: A Review of Patient Decision Support Interventions.

Communicating uncertainty in cancer prognosis: A review of web-based prognostic tools

Construct and criterion validity of the short form-6D utility measure in patients with systemic lupus erythematosus.

Cost-Effectiveness of a School-Based Social and Emotional Learning Intervention: Evidence from a Cluster-Randomised Controlled Trial of the Promoting Alternative Thinking Strategies Curriculum

Delivery of paediatric rheumatology care in the UK--the projected shortfall

Developments in rheumatology consultant manpower provision: the BSR/arc Workforce Register 2003–05

Do patients and health care providers have discordant preferences about which aspects of treatments matter most? Evidence from a systematic review of discrete choice experiments

Does Introducing Imprecision around Probabilities for Benefit and Harm Influence the Way People Value Treatments?

Early cost-effectiveness modeling for better decisions in public research investment of personalized medicine technologies

Economics of stratified medicine in rheumatoid arthritis

Effect of a national primary care pay for performance scheme on emergency hospital admissions for ambulatory care sensitive conditions: controlled longitudinal study

Exploring the mechanisms of change in the chronic disease self-management programme: secondary analysis of data from a randomised controlled trial

Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis

Health state utility values: a description of their development and application for rheumatic diseases

Health-related quality of life, smoking and carotid atherosclerosis in white British women with systemic lupus erythematosus.

How important is mode of administration in treatments for rheumatic diseases and related conditions?

Impact of brand drug discount cards on private insurer, government and patient expenditures

Incentives in Rheumatology: the Potential Contribution of Physician Responses to Financial Incentives, Public Reporting, and Treatment Guidelines to Health Care Sustainability.

Including adverse drug events in economic evaluations of anti-tumour necrosis factor-α drugs for adult rheumatoid arthritis: a systematic review of economic decision analytic models.

Mapping the disease-specific LupusQoL to the SF-6D.

Modelling the cost effectiveness of TNF- antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry

Multivariate meta-analysis of mixed outcomes: a Bayesian approach

OMERACT 10 Patient Perspective Virtual Campus: valuing health; measuring outcomes in rheumatoid arthritis fatigue, RA sleep, arthroplasty, and systemic sclerosis; and clinical significance of changes in health

Operationalizing Neuroimaging for Disorders of Consciousness in the Canadian Context

Parity, time since last live birth and long-term functional outcome: a study of women participating in the Norfolk Arthritis Register ⬇️

Patient Satisfaction and Costs of Multidisciplinary Models of Care in Rheumatology: a Review of the Recent Literature.

Patient-provider communication about medication cost in rheumatoid arthritis

Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensified treatment with traditional disease modifying anti-rheumatic drugs--results of the British Rheumatoid Outcome Study Group randomized controlled clinic

Perspectives of patients, first-degree relatives and rheumatologists on preventive treatments for rheumatoid arthritis: a qualitative analysis

Potential cost-effectiveness for using patient decision aids to guide osteoporosis treatment.

Preferences for ‘New’ Treatments Diminish in the Face of Ambiguity

Preferences of Patients and At-risk Individuals for Preventive Approaches to Rheumatoid Arthritis

Prevalence of autistic spectrum disorders in Lothian, Scotland: an estimate using the "capture-recapture" technique.

Preventing rheumatoid arthritis: Preferences for and predicted uptake of preventive treatments among high risk individuals

Providing an extended use of an otological-specific outcome instrument to derive cost-effectiveness estimates of treatment.

Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register.

Reply

Respondent Understanding in Discrete Choice Experiments: A Scoping Review

Risk as an attribute in discrete choice experiments: a systematic review of the literature.

Same question, different answers: a comparison of global health assessments using visual analogue scales

Societal preferences for rheumatoid arthritis treatments: evidence from a discrete choice experiment

The Impact of Waiting Time on Health Gains from Surgery: Evidence from a National Patient-reported Outcome Dataset ⬇️

The OMERACT Initiative. Towards a reference approach to derive QALY for economic evaluations in rheumatology

The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis

The impact of medication reviews by community pharmacists

The relationship between social deprivation, disease outcome measures, and response to treatment in patients with stable, long-standing rheumatoid arthritis.

The use of routinely collected patient-reported outcome measures in rheumatoid arthritis

UK rheumatology consultant workforce provision 2007-9: results from the BSR/Arthritis Research UK Consultant Workforce Register

Use of Bayesian multivariate meta-analysis to estimate the HAQ for mapping onto the EQ-5D questionnaire in rheumatoid arthritis.

Using Survival Analysis to Improve Estimates of Life Year Gains in Policy Evaluations.

Valuing Health for Clinical and Economic Decisions: Directions Relevant for Rheumatologists

Variation in healthcare services for specialist genetic testing and implications for planning genetic services: the example of inherited retinal dystrophy in the English NHS.

Why do patients with inflammatory arthritis often score states "worse than death" on the EQ-5D? An Investigation of the EQ-5D classification system.